STAT+: Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more
· statnews.com · popularity 33/100 · 0 similar stories today · Personal Finance & Investing (Money, Markets & Investing)
Read the original at statnews.com →
Summary
AstraZeneca has launched a three-year cost-cutting program that aims to slice off $1.5 billion a year, with the savings reinvested in R&D.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 4.